Literature DB >> 4054840

Management of borderline hyperprolactinemia.

E del Pozo.   

Abstract

Progressively increasing plasma prolactin (PRL) concentrations are currently associated with menstrual disturbances, anovulation and cessation of cyclic activity. Galactorrhea-amenorrhea in the presence of normal plasma PRL is rare, but the favorable response to bromocriptine confirms its lactogen dependency. The concept of "transient hyperprolactinemia' is analyzed and alternative explanations for the positive results of dopamine agonist therapy in this particular condition are proposed. Moderate hyperprolactinemia can be associated with luteal inadequacy and infertility. Inhibition of PRL secretion with bromocriptine can normalize luteal function and restore the ability to conceive.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4054840     DOI: 10.1159/000180095

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  2 in total

1.  Prolactin response to thyrotropin-releasing hormone in normoprolactinemic patients with ovulatory dysfunction and its use for selection of candidates for bromocriptine therapy.

Authors:  E Steinberger; S Nader; L Rodriguez-Rigau; C Ayala; K Smith
Journal:  J Endocrinol Invest       Date:  1990-09       Impact factor: 4.256

2.  Changes in serum prolactin level during intracytoplasmic sperm injection, and effect on clinical pregnancy rate: a prospective observational study.

Authors:  Ahmed Kamel; Ayman A Halim; Mohamed Shehata; Salwa AlFarra; Yahia El-Faissal; Wafaa Ramadan; Ahmed M Hussein
Journal:  BMC Pregnancy Childbirth       Date:  2018-05-09       Impact factor: 3.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.